PyroGenesis Canada (PYRGF) Competitors $0.27 0.00 (-0.80%) As of 08/13/2025 01:27 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PYRGF vs. EDIT, LRMR, CRGX, AVTE, MDWD, CRBU, ENGN, ELDN, IPHA, and VTYXShould you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Editas Medicine (EDIT), Larimar Therapeutics (LRMR), CARGO Therapeutics (CRGX), Aerovate Therapeutics (AVTE), MediWound (MDWD), Caribou Biosciences (CRBU), enGene (ENGN), Eledon Pharmaceuticals (ELDN), Innate Pharma (IPHA), and Ventyx Biosciences (VTYX). These companies are all part of the "pharmaceutical products" industry. PyroGenesis Canada vs. Its Competitors Editas Medicine Larimar Therapeutics CARGO Therapeutics Aerovate Therapeutics MediWound Caribou Biosciences enGene Eledon Pharmaceuticals Innate Pharma Ventyx Biosciences PyroGenesis Canada (NASDAQ:PYRGF) and Editas Medicine (NASDAQ:EDIT) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability. Do analysts rate PYRGF or EDIT? Editas Medicine has a consensus target price of $4.90, indicating a potential upside of 62.52%. Given Editas Medicine's stronger consensus rating and higher probable upside, analysts clearly believe Editas Medicine is more favorable than PyroGenesis Canada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Editas Medicine 2 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.31 Does the media refer more to PYRGF or EDIT? In the previous week, Editas Medicine had 10 more articles in the media than PyroGenesis Canada. MarketBeat recorded 10 mentions for Editas Medicine and 0 mentions for PyroGenesis Canada. Editas Medicine's average media sentiment score of 0.15 beat PyroGenesis Canada's score of 0.00 indicating that Editas Medicine is being referred to more favorably in the news media. Company Overall Sentiment PyroGenesis Canada Neutral Editas Medicine Neutral Is PYRGF or EDIT more profitable? PyroGenesis Canada has a net margin of -115.14% compared to Editas Medicine's net margin of -608.88%. PyroGenesis Canada's return on equity of 0.00% beat Editas Medicine's return on equity.Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% N/A -60.81% Editas Medicine -608.88%-157.93%-63.04% Do insiders & institutionals believe in PYRGF or EDIT? 0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 71.9% of Editas Medicine shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by insiders. Comparatively, 2.1% of Editas Medicine shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, PYRGF or EDIT? PyroGenesis Canada has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Editas Medicine has a beta of 2.19, indicating that its share price is 119% more volatile than the S&P 500. Which has better valuation and earnings, PYRGF or EDIT? PyroGenesis Canada has higher earnings, but lower revenue than Editas Medicine. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Editas Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M5.62-$21.12M-$0.03-9.13Editas Medicine$32.31M7.81-$237.09M-$3.04-0.99 SummaryEditas Medicine beats PyroGenesis Canada on 11 of the 17 factors compared between the two stocks. Get PyroGenesis Canada News Delivered to You Automatically Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYRGF vs. The Competition Export to ExcelMetricPyroGenesis CanadaPharmaceutical IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$51.37M$795.26M$7.64B$9.81BDividend YieldN/A4.84%4.56%4.12%P/E Ratio-4.571.1826.0525.74Price / Sales5.6234.2798.82111.33Price / CashN/A19.5628.3558.93Price / Book-27.396.574.356.01Net Income-$21.12M-$4.39M$795.69M$264.84M7 Day Performance-2.39%3.18%0.95%2.66%1 Month Performance-17.00%-1.27%1.92%1.56%1 Year Performance-53.58%19.76%33.77%29.07% PyroGenesis Canada Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYRGFPyroGenesis CanadaN/A$0.27-0.8%N/A-53.6%$51.37M$9.14M-4.5790Gap UpEDITEditas Medicine4.2867 of 5 stars$2.60+1.6%$4.70+80.8%-22.8%$214.30M$32.31M-0.86230News CoverageEarnings ReportAnalyst ForecastGap UpLRMRLarimar Therapeutics3.0432 of 5 stars$3.74+13.0%$18.50+394.7%-50.9%$211.93MN/A-2.5130News CoveragePositive NewsEarnings ReportUpcoming EarningsHigh Trading VolumeCRGXCARGO Therapeutics2.0465 of 5 stars$4.46-0.4%$15.40+245.3%-70.8%$206.57MN/A-0.97116Positive NewsAVTEAerovate TherapeuticsN/A$6.89-4.2%N/A-87.9%$199.71MN/A-2.3020Gap UpHigh Trading VolumeMDWDMediWound1.998 of 5 stars$17.96-2.2%$32.25+79.6%+3.0%$198.54M$20.22M-8.5980News CoverageEarnings ReportCRBUCaribou Biosciences2.928 of 5 stars$2.04-2.9%$8.50+316.7%+4.8%$195.31M$9.99M-1.26100News CoverageEarnings ReportAnalyst RevisionGap DownENGNenGene3.3263 of 5 stars$3.94+3.1%$23.29+491.0%-40.8%$195.22MN/A-2.3931ELDNEledon Pharmaceuticals2.0552 of 5 stars$3.13-3.7%$10.00+219.5%-4.4%$194.62MN/A-1.4910Upcoming EarningsIPHAInnate Pharma3.3178 of 5 stars$2.14+1.4%$11.00+414.0%+2.8%$194.51M$21.77M0.00220Gap UpVTYXVentyx Biosciences2.5296 of 5 stars$2.58-5.1%$10.00+287.6%+46.2%$193.56MN/A-1.4730Earnings Report Related Companies and Tools Related Companies EDIT Alternatives LRMR Alternatives CRGX Alternatives AVTE Alternatives MDWD Alternatives CRBU Alternatives ENGN Alternatives ELDN Alternatives IPHA Alternatives VTYX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYRGF) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PyroGenesis Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PyroGenesis Canada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access